RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 89.85
+4.50 (5.27%)
Mar 10, 2026, 3:35 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 60.37 billion as of March 9, 2026. Its market cap has increased by 320.63% in one year.
Market Cap
60.37B
Enterprise Value
61.48B
Revenue
3.62B
Ranking
n/a
PE Ratio
59.46
Stock Price
89.85
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 60.37B, an increase of 80.79%. That is a compound annual growth rate of 11.75%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 53.95B |
| Sichuan Kelun-Biotech Biopharmaceutical | 90.06B |
| Shanghai Henlius Biotech | 37.50B |
| TransThera Sciences (Nanjing) | 36.71B |
| Akeso | 98.84B |
| Biocytogen Pharmaceuticals (Beijing) | 35.60B |
| Sino Biopharmaceutical | 109.58B |
| Shanghai Junshi Biosciences | 32.13B |